SA19. N-Acetyl-Cysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
about
SA19. N-Acetyl-Cysteine in a Double-Blind Randomized Placebo-Controlled Trial: Toward Biomarker-Guided Treatment in Early Psychosis.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh-hant
name
SA19. N-Acetyl-Cysteine in a D ...... Treatment in Early Psychosis.
@en
SA19. N-Acetyl-Cysteine in a D ...... Treatment in Early Psychosis.
@nl
type
label
SA19. N-Acetyl-Cysteine in a D ...... Treatment in Early Psychosis.
@en
SA19. N-Acetyl-Cysteine in a D ...... Treatment in Early Psychosis.
@nl
prefLabel
SA19. N-Acetyl-Cysteine in a D ...... Treatment in Early Psychosis.
@en
SA19. N-Acetyl-Cysteine in a D ...... Treatment in Early Psychosis.
@nl
P2093
P356
P1476
SA19. -Acetyl-Cysteine in a Do ...... d Treatment in Early Psychosis
@en
P2093
Ann Cousins
Carina Ferrari
Chin B. Eap
Joanne Wojcik
Larry J. Seidman
Lijing Xin
Luis Alameda
Margot Fournier
Martine Cleusix
P304
P356
10.1093/SCHBUL/SBX023.018
P407
P433
P577
2017-03-20T00:00:00Z